408
Views
8
CrossRef citations to date
0
Altmetric
Review

Gastroparesis: pharmacotherapy and cardiac risk

&
Pages 513-518 | Received 08 Aug 2017, Accepted 30 Oct 2017, Published online: 20 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Laura Kreckler, Mark Osinski, Scott Williams & Roger Whiting. (2022) Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis. Journal of Experimental Pharmacology 14, pages 43-57.
Read now

Articles from other publishers (7)

Roger L. Whiting, Agnes Choppin, Gary Luehr & Jeffrey R. Jasper. (2021) Preclinical Evaluation of the Effects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D 2 /D 3 Receptor Antagonist for the Management of Gastroparesis . Journal of Pharmacology and Experimental Therapeutics 379:1, pages 85-95.
Crossref
Roger L. Whiting, Borje Darpo, Chunlin Chen, Margaret Fletcher, Dan Combs, Hongqi Xue & Randall R. Stoltz. (2021) Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK‐906), a Novel Selective D 2 /D 3 Receptor Antagonist: A Phase 1 Randomized, Placebo‐Controlled Single‐ and Multiple‐Dose Escalation Study in Healthy Participants . Clinical Pharmacology in Drug Development 10:8, pages 927-939.
Crossref
S. Soghomonyan, N. Stoicea, W. Ackermann & S. P. Bhandary. (2021) PONV management in patients with QTc prolongation on the EKG. Frontiers in Pharmacology 11.
Crossref
Kieran J. Longley & Vincent Ho. (2020) Practical management approach to gastroparesis. Internal Medicine Journal 50:8, pages 909-917.
Crossref
Ahmad Al‐Saffar, Hans Lennernäs & Per M. Hellström. (2019) Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited. Neurogastroenterology & Motility 31:11.
Crossref
Serhat Bor. (2019) Reflux esophagitis, functional and non-functional. Best Practice & Research Clinical Gastroenterology 40-41, pages 101649.
Crossref
J. R. Giudicessi, M. J. Ackerman & M. Camilleri. (2018) Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias. Neurogastroenterology & Motility 30:6, pages e13302.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.